Advertisement
Screener

Q/C Technologies, Inc. (QCLS) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

Q/C TECHNOLOGIES, INC. PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • Q/C TECHNOLOGIES, INC. pe ratio for the quarter ending 2026-06-30 was -1.93, a change of 50.34 year-over-year.
  • Q/C TECHNOLOGIES, INC. pe ratio for the quarter ending 2026-03-31 was -2.32, a change of 15.3 year-over-year.
  • Q/C TECHNOLOGIES, INC. pe ratio for the quarter ending 2025-12-31 was -2.63, a change of -2.47 year-over-year.
  • Q/C TECHNOLOGIES, INC. pe ratio for the quarter ending 2025-09-30 was -1.58, a change of 15.35 year-over-year.
  • Q/C TECHNOLOGIES, INC. pe ratio for fiscal 2026 was -1.93.
  • Q/C TECHNOLOGIES, INC. pe ratio for fiscal 2025 was -2.63, a change of -2.47 from fiscal 2024.
  • Q/C TECHNOLOGIES, INC. pe ratio for fiscal 2024 was -0.17, a change of 392 from fiscal 2023.
  • Q/C TECHNOLOGIES, INC. pe ratio for fiscal 2023 was -392.17, a change of -93.49 from fiscal 2022.
Available history
2014-03-31 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-1.93$31.94M-$16.57M
2026-03-31-2.32$27.21M-$11.75M
2025-12-31-2.63$30.61M-$11.63M
2025-09-30-1.58$12.33M-$7.8M
2025-06-30-52.27$361.42M-$6.91M
2025-03-31-17.62$258.74M-$14.68M
2024-12-31-0.17$3.87M-$23.36M
2024-09-30-16.93$400.47M-$23.66M
2024-06-30-24.66$436.16M-$17.69M
2024-03-31-41.96$515.67M-$12.29M
2023-12-31-392.17$1.57B-$4M
2023-09-30-15,509.86$83.47B-$5.38M
2023-06-30-14,416.28$189.12B-$13.12M
2023-03-31-16,180.56$203.67B-$12.59M
2022-12-31-298.68$4.54B-$15.2M
2022-09-30-21,035.92$309.05B-$14.69M
2022-06-30-15,047.55$247.76B-$16.47M
2022-03-31-17,206.68$532.05B-$30.92M
2021-12-31-22,914.65$684.9B-$29.89M
2021-09-30-26,193.59$807.25B-$30.82M
2021-03-31-13,873.6$160.87B-$11.6M
2020-12-31-35,933.05$340.93B-$9.49M
2020-09-30-17,964.38$119.61B-$6.66M
2020-06-30-30,068.91$127.89B-$4.25M
2020-03-31-9,446.49$37.34B-$3.95M
2019-12-31-8,586.3$33.39B-$3.89M
2019-09-30-124,174.57$793.04B-$6.39M
2019-06-30-93,888.48$810.58B-$8.63M
2019-03-31-176,224.48$1.75T-$9.91M
2018-12-31-8,108.33$87.97B-$10.85M
2018-09-30-349,314.11$3.85T-$11.03M
2018-06-30-4,597,052.52$41.95T-$9.13M
2018-03-31-10,492,316.65$82.65T-$7.88M
2017-12-31-115,984.87$854.38B-$7.37M
2017-09-30-1,870,387.69$8.31T-$4.44M
2017-06-30-4,340,667.95$12.82T-$2.95M
2017-03-31-5,839,643.15$18.36T-$3.14M
2016-12-31-3,612,652.29$11.93T-$3.3M
2016-09-30-3,647,380.32$21.1T-$5.78M
2016-06-30-2,401,626.52$20.23T-$8.42M
2016-03-31-1,105,312.93$10.5T-$9.5M
2015-12-31-812,086.49$7.56T-$9.31M
2015-09-30-2,808,650.31$18.67T-$6.65M
2015-06-30-4,735,298.68$25.78T-$5.44M
2015-03-31-6,494,913.61$25.13T-$3.87M
2014-12-31-7,246,293.04$22.77T-$3.14M
2014-09-30-6,821,675.11$20.55T-$3.01M
2014-06-30-9,876,457.67$24.02T-$2.43M
2014-03-31-11,780,218.61$25.71T-$2.18M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-1.93$31.94M-$16.57M
2025-12-31-2.63$30.61M-$11.63M
2024-12-31-0.17$3.87M-$23.36M
2023-12-31-392.17$1.57B-$4M
2022-12-31-298.68$4.54B-$15.2M
2021-12-31-22,914.65$684.9B-$29.89M
2020-12-31-35,933.05$340.93B-$9.49M
2019-12-31-8,586.3$33.39B-$3.89M
2018-12-31-8,108.33$87.97B-$10.85M
2017-12-31-115,984.87$854.38B-$7.37M
2016-12-31-3,612,652.29$11.93T-$3.3M
2015-12-31-812,086.49$7.56T-$9.31M
2014-12-31-7,246,293.04$22.77T-$3.14M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92